Abstract
Aged dogs and humans share complex cognitive and pathological responses to aging. Specifically, dogs develop Alzheimers Disease (AD) like beta-amyloid (Aβ) that are associated with cognitive deficits. Currently, therapeutic approaches to prevent AD are targeted towards reduced production, aggregation and increased clearance of Aβ. The current review discusses cognition and neuropathology of the aging canine model and how it has and continues to be useful in further understanding the safety and efficacy of potential AD prevention therapies targeting A
Keywords: Alzheimer's disease, canine, statins, BACE-1 inhibitors, metal-chelators, A-beta vaccination
Current Neuropharmacology
Title: Therapeutic Interventions Targeting Beta Amyloid Pathogenesis in an Aging Dog Model
Volume: 9 Issue: 4
Author(s): Sarah B. Martin, Amy L.S. Dowling and Elizabeth Head
Affiliation:
Keywords: Alzheimer's disease, canine, statins, BACE-1 inhibitors, metal-chelators, A-beta vaccination
Abstract: Aged dogs and humans share complex cognitive and pathological responses to aging. Specifically, dogs develop Alzheimers Disease (AD) like beta-amyloid (Aβ) that are associated with cognitive deficits. Currently, therapeutic approaches to prevent AD are targeted towards reduced production, aggregation and increased clearance of Aβ. The current review discusses cognition and neuropathology of the aging canine model and how it has and continues to be useful in further understanding the safety and efficacy of potential AD prevention therapies targeting A
Export Options
About this article
Cite this article as:
B. Martin Sarah, L.S. Dowling Amy and Head Elizabeth, Therapeutic Interventions Targeting Beta Amyloid Pathogenesis in an Aging Dog Model, Current Neuropharmacology 2011; 9 (4) . https://dx.doi.org/10.2174/157015911798376217
DOI https://dx.doi.org/10.2174/157015911798376217 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Quality, not Quantity: The Role of Natural Products and Chemical Proteomics in Modern Drug Discovery
Combinatorial Chemistry & High Throughput Screening Journal Current Genomics: News and Editorial Prospects
Current Genomics Synthesis and Antioxidant Properties of Novel Memantine Derivatives
Central Nervous System Agents in Medicinal Chemistry Meet Our Editor
Letters in Drug Design & Discovery Serotonin and its Receptors in the Human CNS with New Findings - A Mini Review
Current Medicinal Chemistry The Prevalence of Depression in Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Current Alzheimer Research <i>Lepidium meyenii</i> Supplemented Diet Modulates Neurobehavioral and Biochemical Parameters in Mice Fed High-Fat High-Sugar Diet
Endocrine, Metabolic & Immune Disorders - Drug Targets The Potential Role of Pro-Inflammatory and Anti-Inflammatory Cytokines in Epilepsy Pathogenesis
Endocrine, Metabolic & Immune Disorders - Drug Targets Developing Novel Therapeutic Approaches to Frailty
Current Pharmaceutical Design Aging Changes in Satellite Cells and Their Functions
Current Aging Science Alcoholic Liver Disease and Hepatitis C Chronic Infection
Reviews on Recent Clinical Trials Possibility that the Onset of Autism Spectrum Disorder is Induced by Failure of the Glutamine-Glutamate Cycle
Current Molecular Pharmacology Serotonin Reuptake Inhibition: An Update on Current Research Strategies
Current Medicinal Chemistry NLRP3 Inflammasome in the Pathophysiology of Hemorrhagic Stroke: A Review
Current Neuropharmacology Simvastatin and Other HMG-CoA Reductase Inhibitors on Brain Cholesterol Levels in Alzheimers Disease
Current Alzheimer Research Midkine: A Promising Molecule for Drug Development to Treat Diseases of the Central Nervous System
Current Pharmaceutical Design Gap Junctions as Therapeutic Targets in Brain Injury Following Hypoxia- Ischemia
Recent Patents on CNS Drug Discovery (Discontinued) Multitarget Opioid/Non-opioid Ligands: A Potential Approach in Pain Management
Current Medicinal Chemistry G-Protein Coupled Receptor Resensitization - Appreciating the Balancing Act of Receptor Function
Current Molecular Pharmacology Better Antiretroviral Central Nervous System Penetration is Not Associated with Reduced Chronic Pain in People Living with Human Immunodeficiency Virus
Anti-Infective Agents